Expression and molecular consequences of inhibition of estrogen receptors in granulosa cells of bovine follicles by Monique Tomazele Rovani et al.
Rovani et al. Journal of Ovarian Research 2014, 7:96
http://www.ovarianresearch.com/content/7/1/96RESEARCH Open AccessExpression and molecular consequences of
inhibition of estrogen receptors in granulosa cells
of bovine follicles
Monique Tomazele Rovani1,4, Bernardo Garziera Gasperin2, Gustavo Freitas Ilha1,4, Rogério Ferreira3,
Rodrigo Camponogara Bohrer4, Raj Duggavathi4, Vilceu Bordignon4 and Paulo Bayard Dias Gonçalves1*Abstract
Background: Estradiol (E2) receptors mediate E2 effects on cell proliferation and apoptosis under normal and
pathological conditions. However, the mechanisms involved in E2 signaling are not completely understood. The
objectives in this study were to evaluate the expression of estrogen receptors (ESRs) during follicular selection in
cattle, and the effect of intrafollicular injection of fulvestrant (an antagonist of ESRs) on follicular development and
transcript abundance in granulosa cells.
Methods: Granulosa cells were obtained from the two largest follicles around follicular deviation, after FSH
treatment and after intrafollicular injection of fulvestrant. Ovarian follicular dynamics monitored by ultrasonography
and quantitative real time PCR were used to validate the in vivo model and investigate the effects of FSH
supplementation or ESR blockade on mRNA expression of estradiol-related genes.
Results: ESR1 and ESR2 were expressed in granulosa cells of both dominant (F1) and subordinate (F2) follicles, but
their transcripts levels were higher in F1 than F2 after follicular deviation. FSH treatment maintained mRNA levels of
both ESR1 and ESR2 in F2 follicles at similar levels observed in F1 follicles. Intrafollicular injection of 100 μM
fulvestrant inhibited follicular growth and decreased CYP19A1 mRNA levels. Transcript levels for both ESR1 and ESR2
were not affected by fulvestrant injection. Analyses of FSH-regulated genes revealed that ESRs inhibition in the
dominant follicle decreased the transcript levels of the GJA1 but not those of PRKAR2B, MRO or LRP11 genes.
Conclusions: Our findings indicate that: both ESR1 and ESR2 are regulated during follicular deviation and
dominance in cattle and in response to FSH treatment, and ESRs are required for normal gene expression and
development of the dominant follicle. Furthermore, we have validated an in vivo model to study estrogen signaling
during follicular development that allows paracrine signaling between different follicular cells in a physiological
endocrine environment.
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Follicular deviation is characterized by the selection of one
follicle while the other follicles become atretic. Dominant
follicles (F1) have greater concentrations of estradiol (E2)
in follicular fluid when compared to subordinate follicles
(F2) [1,2]. It has been shown that E2 protects granulosa
cells from apoptosis, promoting cell cycle progression in* Correspondence: bayard@ufsm.br
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unless otherwise stated.healthy follicles [3], whereas subordinate follicles lose their
ability to produce E2 and undergo atresia [4]. Besides its
pivotal role during normal follicle development, E2 sig-
naling also regulates ovarian cancer cell proliferation
and apoptosis [5], being ESRs important prognostic
biomarkers for ovarian cancer [6].
It is well established that E2 signaling is mediated by the
intracellular receptors estrogen receptor 1 (ESR1) and es-
trogen receptor 2 (ESR2), which are members of the nu-
clear receptor superfamily [7]. In mouse ovaries, ESR1 is
mainly expressed in interstitial cells, whereas ESR2 isLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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females lacking Esr1 gene are infertile and non-receptive to
males, which indicates defective estrogen response in the
central nervous system [9]. In order to circumvent the lack
of ESR1-mediated action in the hypothalamic-pituitary
axis, Couse et al. [10] administrated exogenous gonadotro-
pins to Esr1 knockout mice and confirmed that ESR1 is re-
quired for ovulation. On the other hand, Esr2 knockout
mice have lower number of growing follicles and reduced
litter size compared to wild-type females [11].
Differentiation of granulosa cells in response to FSH is
enhanced by estrogen [12,13]. Using in vitro knockout
approaches, it was observed that ESR2 mediates estro-
gen actions. Indeed, ESRs were shown to be essential for
differentiation of mouse granulosa cells in response to
FSH, and a critical factor for expression of LH receptor
(LHCGR) but not for FSH receptor (FSHR) [14,15]. It
was also demonstrated that ESR2 deletion impairs the
cAMP pathway response to FSH, changing the pattern
of global gene expression and attenuating the expression
of various FSH-regulated genes [15]. In cattle, it was
shown that ESR2 mRNA expression is up regulated in
fully differentiated follicles compared to subordinate fol-
licles between days 2 and 3.5 of the estrous cycle [16].
However, the expression pattern of ESRs before, during
and after follicle deviation has not been demonstrated.
Moreover, the consequences of pharmacologic inhibition
of ESRs during bovine follicular growth have not been
investigated.
Intrafollicular injection in live animals represents an
invaluable tool to investigate the physiological roles of
ESRs during folliculogenesis. Indeed, the possibility of
performing follicular manipulations in vivo while main-
taining the complex follicular ultrastructure and cellular
interactions circumvents the limitations of the in vitro
models. Fulvestrant (ICI 182,780) is an antiestrogen that
competes with E2 for binding to ESRs with no agonist
activity [17]. Fulvestrant binds to ESRs and prevents their
dimerization. The formed fulvestrant-ESR complexes are
not translocated into the nucleus thereby culminating in
the degradation of the complex [18].
In this study, we have used cattle as an in vivo model
to: a) investigate the expression pattern of ESRs in the
two largest follicles collected before, at the expected
time-point, and after follicular deviation; b) evaluate the
effect of FSH on ESRs expression; and c) determine the
effects of ESRs inhibition on follicular development, and
expression of ESRs and FSH-regulated genes in granu-
losa cells of developing follicles.
Methods
Animals
All procedures were approved by the Institutional Com-
mittee for Ethics in Animal Experiments at the FederalUniversity of Santa Maria, RS, Brazil. Adult cyclic Bos
taurus taurus beef cows were used in this study.
Estrus synchronization and follicular growth monitoring
Cows used in experiments 1 and 2 (detailed below) were
synchronized with two doses of a prostaglandin F2α (PGF2α)
analogue (cloprostenol, 250 μg; Schering-Plough Animal
Health, Brazil) given intramuscularly (i.m.) 11 days apart.
Animals observed in estrus within 3–5 days after the second
PGF2α administration were included in the experiments.
Cows used in experiment 3 were treated with a pro-
gesterone releasing intravaginal device (1 g progesterone,
DIB – Intervet Schering Plough, Brazil), an im injection
of 2 mg estradiol benzoate (Genix, Anápolis, Brazil) to
induce follicular regression and emergence of a new
follicular wave, and two (12 h apart) im injections of
PGF2α. Four days later, the progesterone device was
removed and ovaries were monitored daily for at least
3 days before treatment to ensure that new follicles
were growing and persistent follicles were not present
in the ovaries. Only cows without a corpus luteum in
an ultrasound exam were included in the study to
avoid progesterone inhibitory effects during the final
stage of follicular growth and ovulation.
In all experiments, ovaries were examined once a day by
transrectal ultrasonography, using an 8 MHz linear-array
transducer (Aquila Vet scanner, Pie Medical, Netherlands)
and all follicles larger than 5 mm were drawn using 3 to 5
virtual slices of the ovary allowing a three-dimensional
localization of follicles and monitoring individual follicles
during follicular wave [19].
Ovary collection and isolation of granulosa cells
Cows were ovariectomized by colpotomy under caudal
epidural anesthesia [20]. Ovaries were washed with saline
and granulosa cells were harvested from follicles through
repeated flushing with PBS. Cell samples were immedi-
ately stored in liquid nitrogen for further analyses.
RNA extraction, reverse transcription and real-time PCR
Total RNA was purified from granulosa cells using silica-
based protocol (Qiagen, Mississauga, ON, Canada) ac-
cording to the manufacturer’s instructions. Quantitation
and estimation of RNA purity was performed using a Nano-
Drop spectrophotometer (Thermo Scientific - Waltham,
USA; Abs 260/280 nm ratio). Ratios above 1.8 were consid-
ered pure, and samples below this threshold were discarded.
Complementary DNA was synthesized from 500 ng RNA,
which was first treated with 0.1 U DNase, Amplification
Grade (Life Technologies, Burlington, ON) for 5 min
at 37°C. After DNase inactivation at 65°C for 10 min,
samples were incubated in a final volume of 20 μl with
iScript cDNA Synthesis Kit (BioRad, Hercules, CA).
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steps: 25°C – 5 min, 42°C – 30 min and 85°C – 5 min.
To test cross-contamination with theca cells, quantita-
tive PCR detection of Cytochrome P450, family 17, sub-
family A, polypeptide 1 mRNA (CYP17A1; NM_174304.2;
F: CCATCAGAGAAGTGCTCCGAAT; R: GCCAATGC
TGGAGTCAATGA) was performed in granulosa cells.
Samples were considered free of contamination if CYP17A1
was not amplified within 30 PCR cycles. Quantitative poly-
merase chain reactions (qPCR) were conducted in a
CFX384 thermocycler (BioRad) using iQ SYBR Green
Supermix (BioRad) and bovine-specific primers (Table 1)
taken from the literature or designed using the Primer Ex-
press Software (Applied Biosystems). Standard two-step
qPCR was performed with initial denaturation at 95°C for
5 min followed by 40 cycles of denaturation at 95°C for
15 sec and annealing/extension at 58°C for 30 sec.
Melting-curve analyses were performed to verify prod-
uct identity.
To optimize the qPCR assay, serial dilutions of cDNA
templates were used to generate a standard curve. The
standard curve was constructed by plotting the log of
the starting quantity of the dilution factor against the Ct
value obtained during amplification of each dilution. Re-
actions with a coefficient of determination (R2) higher
than 0.98 and efficiency between 95 to 105% were consid-
ered optimized. The relative standard curve method was
used to assess the amount of a particular transcript inTable 1 List of primers used in the qPCR reactions
Gene name Primer sequence (5′ to 3′) Reference or
accession no.
CYP19A1 F: GTGTCCGAAGTTGTGCCTATT [21]
R: GGAACCTGCAGTGGGAAATGA
ESR1 F: CCAACCAGTGCACGATTGAT NM_001001443.1
R: TTCCGTATTCCGCCTTTCAT
ESR2 F: CAGCCGTCAGTTCTGTATGCA NM_174051.3
R: TCCTTTTCAATGTCTCCCTGTTC
FSHR F: AGCCCCTTGTCACAACTCTATGTC [21]
R: GTTCCTCACCGTGAGGTAGATGT
GJA1 F: GTCTTCGAGGTGGCCTTCTTG NM_174068.2
R: AGTCCACCTGATGTGGGCAG
LHCGR F: GCACAGCAAGGAGACCAAATAA NM_174381.1
R: TTGGGTAAGCAGAAACCATAGTCA
LRP11 F: CCAGAAAGTCGCATTGATCTTG NM_001206831.1
R: TGTTCCCCTCCTCCTCGATT
MRO F: CCCACTTACAGGACAGGAATCC NM_001034552.1
R: TGGAAGCTGTAGTCCTTGCTTTG
PRKAR2B F: GGGCATTCAACGCTCCAGTA NM_174649.2
R: CTGGATTCAGCATCATCTTCTTCTT
F, Forward primers; R, Reverse primers.each sample [22]. Samples were run in duplicate and re-
sults are expressed relative to GAPDH (NM_001034034.2;
F: ACCCAGAAGACTGTGGATGG; R: CAACAGA
CACGTTGGGAGTG), cyclophilin B (NM_174152.2; F:
GGTCATCGGTCTCTTTGGAA; R: TCCTTGATCAC
ACGATGGAA), RPL19 (NM_001040516.1; F: GCCAA
CTCCCGTCAGCAGA; R: TGGCTGTACCCTTCCGC
TT) and/or RPLP0 (NM_001012682.1; F: GGCGACC
TGGAAGTCCAACT; R: CCATCAGCACCACAGCCT
TC) or the average Ct values for these genes as internal
controls. The selection of the internal control genes was
based on the Ct variance (as reflected by the standard de-
viation) among groups in each experiment.
Experiment 1: Estrogen receptors expression in granulosa
cells around the period of follicle deviation
Thirty-two cows were synchronized, of which the fifteen
cows that were detected in estrus 3 to 5 days after the
second PGF2α administration were ovariectomized at
specific stages of the first follicular wave. The day of fol-
licular emergence was designated as day-0 of the wave
and was retrospectively identified as the last day on
which the dominant follicle was 4 to 5 mm in diameter
[23]. Separate groups of cows were randomly assigned
for ovariectomy on days-2 (n = 4), 3 (n = 4) or 4 (n = 7)
of the follicular wave to recover the two largest follicles
from each cow. This approach allowed us to investigate
transcript abundance of ESRs and related genes when
the size of the largest and second largest follicle did not
have a significant difference (day-2 of the follicular
wave), had slight difference (day-3) or marked difference
(day-4). These time-points correspond to before, during
and after the dominant follicle selection, respectively.
Experiment 2: Estrogen receptor expression after FSH
treatment
This experiment was conducted to compare mRNA
levels of ESR genes between the two largest follicles col-
lected from FSH (n = 3) and saline (n = 4) treated cows.
FSH treated cows received two doses of 30 mg FSH
(Folltropin-V, Bioniche Animal Health, Ontario, Canada)
on the second day of the estrous cycle followed by two
doses of 20 mg on the third day. Control cows were
injected at the same time with saline. Ovaries were col-
lected 12 hours after the last FSH/saline treatment and
granulosa cells were recovered as described above.
Experiment 3: Effect of intrafollicular administration of an
estrogen receptor inhibitor on follicular development and
gene expression in granulosa cells
To determine the effective dose of the estrogen receptor
inhibitor, fulvestrant (Sigma–Aldrich, Brazil), nine adult
cyclic cows were synchronized as detailed above and their
ovaries were monitored by transrectal ultrasonography.
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diameter between 7 to 8 mm, which represents the size
when the future dominant follicle is reliably identifiable
[24,25], it was injected with 1, 10 or 100 μM (n =3/group)
fulvestrant. Intrafollicular injection and adjustment of ful-
vestrant amount to be injected according to follicular size
were performed as previously described [26]. The develop-
ment of the injected follicles was monitored by daily ultra-
sound examination for three days after treatment.
Based on the inhibition of follicular growth (see the Re-
sults), the highest concentration of fulvestrant (100 μM)
was chosen to evaluate the effect of ESRs inhibition on
gene expression in granulosa cells. Six cows were synchro-
nized and their future dominant follicle was injected intra-
follicularly with fulvestrant or saline (n = 3 per group).
Cows were ovariectomized at 12 h after intrafollicular in-
jection to harvest granulosa cells.
Statistical analyses
Variation in transcript levels was analysed by ANOVA and
multiple comparisons between days or groups were per-
formed by LSMeans Student’s t test using the JMP Soft-
ware. Continuous data were tested for normal distribution
using Shapiro–Wilk test and normalized when necessary.
The effect of fulvestrant on follicular development was
performed as repeated measures data using the MIXED
procedure with a repeated measure statement using the
SAS Software package (SAS Institute, Inc., Cary, NC,
USA). Main effects of treatment group, day, and their
interaction were determined. Differences between follicu-
lar sizes at a specific time point were compared between
groups using estimates. Differences between the two lar-
gest follicles were accessed by paired Student’s t-test using
cow as subject. Results are presented as means ± S.E.M.
P ≤0.05 was considered statistically significant.Figure 1 Relative mRNA abundance in bovine granulosa cells during
collected from the ovaries of 15 cows on days – 2 (n =4), 3 (n =4) or 4 (n =
ESR2 genes are expressed as mean ± SEM. * indicates statistical difference (Results
Expression of ESRs during follicular selection and
dominance
The respective diameters of the largest (F1) and the sec-
ond largest (F2) follicles collected before (day-2), during
(day-3) and after (day-4) deviation were 7.3 ± 0.2 mm
and 6.4 ± 0.1 mm (P >0.05), 8.1 ± 0.2 mm and 6.5 ±
0.4 mm (P >0.05), and 9.5 ± 0.2 and 6.8 ± 0.1 (P <0.0001).
Using the same experimental model, we have previously
shown that estradiol concentrations increased in the
follicular fluid of F1 (dominant) follicles from day 2 to
4, but decreased in F2 (subordinate) follicles on days 3
and 4 [24].
In order to validate the in vivo experimental models,
we first assessed mRNA levels of Cytochrome P450,
family 19, subfamily A, polypeptide 1 (CYP19A1) and
LH receptor (LHCGR) genes in granulosa cells from the
largest and second largest follicles on days-2 (n = 4), 3
(n = 4) or 4 (n = 7) of the follicular wave. Subordinate
follicles expressed low levels of CYP19A1 and LHCGR
(Figure 1) during (day-3) and after (day-4) the expected
time of follicular deviation. The relative mRNA abundance
of ESR1 and ESR2 in granulosa cells was then compared
between the largest (F1) and second largest (F2) follicles
(Figure 1). While mRNA levels of ESRs were similar be-
tween F1 and F2 follicles before (day-2) and at (day-3) the
expected time of follicular deviation, both ESR1 and ESR2
transcripts were higher (P <0.05) in F1 than F2 follicles
after deviation (day-4).
Effect of FSH treatment on ESR expression
Based on the findings of the first study we evaluated
whether FSH treatment would maintain normal expres-
sion of ESRs in the second largest follicles. Similarly to
the first experiment, we confirmed that mRNA levels offollicular deviation. The two largest follicles from each cow were
7) of the first follicular wave. Abundance of CYP19A1, LHCGR, ESR1 and
P ≤0.05) between the largest (F1) and second largest (F2) follicles.
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after deviation (Figure 2). Yet, there was no difference
(P > 0.05) in either ESR1 or ESR2 mRNA levels be-
tween F1 and F2 follicles collected from FSH-treated
animals (Figure 2). CYP19A1 mRNA abundance did
not differ (p > 0.05) between F1 (0.6 ± 0.13) and F2
(0.33 ± 0.11) follicles of FSH-treated cows, but was sig-
nificantly higher (p < 0.05) in F1 (1 ± 0.18) compared to F2
(0 ± 0) follicles from control cows.Figure 3 Effect of intrafollicular injection of an estrogen-receptor
antagonist (fulvestrant) on follicular growth. A new follicular wave
was induced (detailed in Methods) and 1, 10 or 100 μM fulvestrant
(n = 3/group) was intrafollicularly injected when the largest follicle
reached a diameter between 7 to 8 mm. Follicular diameters were
monitored by daily ultrasound examinations until 72 h after
intrafollicular treatment. Different letters indicate significant
differences (P ≤0.05) between treatments within a time.Effect of intrafollicular inhibition of ESRs on follicular
development and ESRs expression
Our next objective was to evaluate the consequences of
inhibiting ESRs in growing follicles around the time of
follicular deviation. We first monitored follicular growth
in response to intrafollicular injection of 1, 10 or 100 μM
fulvestrant in follicles having an average diameter of 8.8 ±
0.6, 7.8 ± 0.1 and 8.1 ± 0 mm (P >0.05), respectively.
While follicular development was inhibited by the higher
concentrations (10 and 100 μM) of fulvestrant (Figure 3;
P ≤0.01), follicles injected with 1 μM continued devel-
oping. This confirmed that the inhibition of follicular
growth was specifically due to the higher concentration ofFigure 2 Relative mRNA abundance in granulosa cells of the
two largest follicles in saline or FSH-treated cows. Cows were
treated twice a day (12 h apart) with FSH (30, 30, 20 and 20 mg) or
saline (control) starting on day 2 after ovulation. Granulosa cells
were collected from the two largest follicles 12 h after the last
administration of FSH (n = 4 pairs) or saline (n = 3 pairs). Abundance
of ESR1 and ESR2 are expressed as mean ± SEM. * indicates statistical
difference (P ≤0.05) between largest and second largest follicles.fulvestrant rather than as a consequence of the intrafolli-
cular injection procedure.
As expected, intrafollicular inhibition of ESRs with
100 μM fulvestrant resulted in decreased abundance
(P ≤0.05) of mRNA encoding CYP19A1 (Figure 4).
However, mRNA levels of LHCGR, ESR1 and ESR2
were not different between control and fulvestrant-
injected follicles (Figure 4).
Effect of ESRs inhibition on the expression of FSH-
regulated genes in granulosa cells
Our final objective was to evaluate the effect of intrafol-
licular administration of 100 μM fulvestrant on granu-
losa cell gene expression. The diameters of F1 and F2
follicles used in this experiment were 9.5 ± 1.3 mm and
6.1 ± 0.6 mm (P <0.05) in the control group, and 8.6 ±
0.9 mm and 7.5 ± 0.7 mm (P >0.05) in the FSH-treated
group. We focused on FSH-regulated genes such as Gap
junction protein alpha 1 (GJA1), Maestro (MRO), Low
density lipoprotein receptor-related protein 11 (LRP11),
FSHR and Protein kinase, cAMP-dependent, regulatory,
type II, beta (PRKAR2B), as these were reported to be
downregulated in granulosa cells of Esr2 null mice [15].
We first examined if these genes are indeed differentially
regulated in dominant and subordinate follicles using
granulosa cells of F1 and F2 collected on day 4 of the
follicular wave (Experiment 1). Relative mRNA levels of
GJA1, MRO, LRP11, FSHR, but not PRKAR2B, were
higher (P ≤0.05) in granulosa cells of F1 than F2 follicles
(Figure 5A). However, in granulosa cells of fulvestrant-
treated follicles only GJA1 mRNA was lower (P ≤0.05)
compared to granulosa cells of control follicles (Figure 5B).
Fulvestrant treatment did not affect (P >0.05) the abun-
dance of mRNA encoding PRKAR2B, MRO, LRP11 and
Figure 4 Relative mRNA abundance in granulosa cells of the largest follicle after intrafollicular injection of fulvestrant. A new
follicular wave was induced (detailed in Methods) and 100 μM fulvestrant or saline was intrafollicularly injected when the largest follicle
reached a diameter between 7 to 8 mm. Granulosa cells were recovered from saline (n = 3) and fulvestrant (n = 3) treated follicles at 12 h
after intrafollicular injection. Abundance of CYP19A1, LHCGR, ESR1 and ESR2 genes are expressed as mean ± SEM. * indicates statistical
difference (P ≤0.05) between groups.
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(Figure 5B).
Discussion
In this study, cattle were used as an in vivo model to inves-
tigate regulation of ESR 1 and 2 during follicular deviation
in a monovular species, and the effects of intrafollicular in-
hibition of ESRs on follicular growth and gene expression.
We observed that: expression of ESR1 and 2 was higher in
granulosa cells of the largest compared to second largest
follicle after deviation; FSH maintained expression of both
ESRs in the second largest follicles beyond the follicular
deviation; inhibition of ESRs abrogated follicular growth
without decreasing their transcript levels and; FSH-
regulated genes respond differently to intrafollicular
inhibition of ESRs in growing follicles.
Studies with mice have established that ESR2 is the re-
ceptor responsible for mediating estrogen actions in
granulosa cells [8,14,15]. However, ESR1 has been pro-
posed to be the main receptor involved in follicular de-
velopment in cattle [27]. This suggests that regulation of
ESRs may differ between monovulatory and polyovula-
tory species. In this study, we have confirmed that both
ESR1 and ESR2 are expressed in granulosa cells during
follicular selection in cattle. While the expression of
ESR1 and ESR2 was significantly decreased in granulosa
cells of the subordinate follicle after deviation, both ESRs
were constitutively expressed in the selected dominant
follicle. It is therefore possible that both receptors are re-
quired for the continued development of the dominant
follicle during and after follicular deviation in cattle. Our
primary objective in this study was to characterize the
expression of ESRs before, during and after follicledeviation. Although expected to be regulated before
follicle deviation, we observed that both ESR1 and ESR2
were regulated after deviation. This suggests that ESRs are
not involved in follicular selection, but they are necessary
to maintain follicular development of the selected follicles.
Although previous studies in rats have shown that
hypophysectomised females express ESRs in granulosa
cells in response to FSH [28], the effect of FSH treat-
ment on the expression of ESRs during follicular growth
has not been thoroughly investigated in cattle. Herein,
we found that FSH maintained the expression of both
ESR1 and ESR2 in the second largest follicle at similar
levels observed in the largest follicle, while mRNA levels
for both ESRs were reduced in the second largest follicle
of saline treated cows. This suggests that similar to ro-
dents, FSH promotes the expression of both ESRs in
granulosa cells during follicular growth and selection in
cattle.
To further investigate the roles of ESRs during follicu-
lar growth, we performed in vivo intrafollicular adminis-
tration of the ESRs antagonist fulvestrant in cows.
Fulvestrant is known to disrupt the dimerization and ac-
celerate the degradation of ESRs [29,30]. We first con-
firmed that fulvestrant injection suppresses follicular
growth in a dose depend manner, which, in addition to
validate our in vivo model, indicated that ESRs are re-
quired for continued development of the dominant fol-
licle after deviation in cattle. Intrafollicular injection in
cattle is a well-established technique. We and others
have previously shown that this procedure did not affect
follicle growth and ovulation [25,26,31,32]. Indeed, the
fact that follicles injected with the lower concentration
of fulvestrant (1 μM) continued to grow indicates that
Figure 5 Relative mRNA abundance in granulosa cells after follicular deviation (A) and after fulvestrant treatment (B). Abundance of
GJA1, PRKAR2B, MRO, LRP11 and FSHR genes are expressed as mean ± SEM. In A, asterisk (*) indicates statistical difference (P ≤0.05) between
largest (F1) and second largest (F2) follicles after follicular deviation. In B, asterisk (*) indicates statistical difference (P ≤0.05) between groups:
intrafollicular injection of saline or fulvestrant.
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with follicular development. Moreover, our data clearly
show that only the higher concentrations of fulvestrant
(10 or 100 μM) were able to block follicular growth and
reduce CYP19A1 mRNA levels in granulosa cells. Estra-
diol concentrations were not determined in this study
because we have previously reported that estradiol tended
to be lower in the follicular fluid of fulvestrant-treated fol-
licles compared to control follicles [33]. The inhibition of
estrogen binding to its receptors by fulvestrant injection
decreased the expression of CYP19A1, the enzyme re-
sponsible for androgen aromatization to estrogen, suggest-
ing that estrogen regulates its own synthesis [34,35]. Thisis supported by our results from the follicular deviation
model, where CYP19A1 mRNA levels were lower in sub-
ordinate follicles collected on day- 3 and 4, which are
known to have low estrogen levels [24,33]. Moreover, es-
trogen treatment has been shown to increase ESRs ex-
pression in granulosa cells of hypophysectomised rats
[28]. On the other hand, we observed that transcripts
levels of ESR1 and ESR2 were not affected by fulvestrant
treatment. The aforementioned results validate fulvestrant
intrafollicular injection as a valuable model to study estra-
diol signaling in granulosa cells. However, a model to
study the specific functions of ESR1 and ESR2 still needs
to be validated.
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regulated genes that require Esr2 for normal expression.
Indeed, granulosa cells lacking Esr2 had lower transcript
levels of Comp, Mro and Lrp11 genes after gonadotropin
stimulation, whereas Prkar2b expression was not affected.
In the present study, we observed no differences in tran-
script abundance of PRKAR2B, MRO or LRP11 genes in
response to inhibition of ESR signaling. This suggests that
pharmacological inhibition of ESRs was not sufficient to
downregulate MRO and LRP11 in monovulatory com-
pared to polyovulatory species. It is still possible that gen-
etic deletion of ESRs may result in phenotype similar to
rodents. On the other hand, we observed that follicles
treated with fulvestrant had significantly decreased mRNA
levels of GJA1 compared to control follicles. The GJA1
provides the communication among granulosa cells via
gap junction channels, and it was shown to be highly
expressed in granulosa cells of rat follicles [36]. It has been
well established that GJA1 is the most important connexin
that makes a significant contribution to intercellular coup-
ling in mouse granulosa cells and Gja1 null mice exhibit
aberrant follicular growth [37]. It has also been reported
that GJA1 mRNA and protein decrease during follicular
atresia induced by E2 withdrawal in rodents [38]. Our
findings with intrafollicular injection of fulvestrant dem-
onstrate that the ESR signalling is necessary for GJA1
expression in granulosa cells of growing follicles of
monovulatory species. Further, these observations indi-
cate that inhibition of ESRs abrogates follicular growth
at least in part through deregulated intercellular com-
munication among granulosa cells. Taken together, our
results indicate that the in vivo model used in this
study represents an important asset to investigate steroid
hormones signaling mechanisms in the ovary, which is
needed for advancing our understanding of both physio-
logical and pathological conditions [6].
Conclusions
Using an in vivo model of a monovulatory species, we
have shown that both ESR1 and ESR2 are regulated in
granulosa cells during follicular deviation and domin-
ance, and in response to FSH treatment. Moreover, by
intrafollicular injection of an antagonist, we confirm that
ESRs are required for the normal development of the
dominant follicle in cattle. Finally, we propose that intra-
follicular injection in cattle is a suitable in vivo model to
study estrogen signaling during follicular deviation and
dominance in monovulatory species.
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